Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
BACKGROUND: Venous thromboembolism comprising pulmonary embolism and deep vein thrombosis is a common condition with an incidence of approximately 1 per 1,000 per annum causing both mortality and serious morbidity. The principal aim of treatment of a venous thromboembolism with heparin and warfarin...
Main Authors: | Tullett, J, Murray, E, Nichols, L, Holder, R, Lester, W, Rose, P, Hobbs, F, Fitzmaurice, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2013
|
Similar Items
-
ExACT: Extended anticoagulation treatment for VTE: a randomised trial
by: Fitzmaurice, D, et al.
Published: (2011) -
A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)
by: Bradbury, C, et al.
Published: (2019) -
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
by: Sake J. van der Wall, et al.
Published: (2018-11-01) -
Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE—Results from the ExACT randomised controlled trial.
by: Charlotte Bradbury, et al.
Published: (2019-12-01) -
Extended anticoagulation for VTE: what evidence justifies it?
by: Anushka Walia, et al.
Published: (2023-08-01)